Clinical Trial Update: SPHERIC-1. Sildenafil and Pulmonary HypERtension In COPD [Phase 3]

View source ↗

Summary

An update on the Phase 3 SPHERIC-1 trial evaluating sildenafil for pulmonary hypertension in COPD; the status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Italian Association of Hospital Pneumologists | Conditions: Pulmonary Hypertension, COPD | Phase 3 | Status: UNKNOWN